Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API

TECH
Bio-Techne Corp.
stock NASDAQ

At Close
Jul 1, 2026 4:00:00 PM EDT
70.98USD+0.467%(+0.33)11,877,092
0.00Bid   0.00Ask   0.00Spread
Pre-market
Jul 1, 2026 9:27:30 AM EDT
70.71USD+0.085%(+0.06)1,005
After-hours
Jul 1, 2026 4:34:30 PM EDT
70.81USD-0.240%(-0.17)844,203
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsDividendsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 18, 2022
07:13AM EST  Bio-Techne Announces Commercial Release Of High Sensitivity Fluorescent Detection Stellar NIR/IR Modules For Jess Automated Western Blotting System   Benzinga
07:01AM EST  DETECTION STELLAR NIR / IR(tm) MODULES FOR JESS AUTOMATED WESTERN BLOTTING SYSTEM   PR Newswire
Jan 17, 2022
08:00AM EST  BIO-TECHNE TO HOST CONFERENCE CALL ON FEBRUARY 1, 2022 TO ANNOUNCE SECOND   PR Newswire
Jan 7, 2022
04:01PM EST  BIO-TECHNE ANNOUNCES UPDATED PRESENTATION TIME AT THE J.P. MORGAN HEALTHCARE   PR Newswire
Jan 5, 2022
07:07AM EST  Akoya Biosciences And Bio-Techne Partner To 'Deliver Automated Spatial Multiomics Workflow with Industry-Leading Speed and Resolution'   Benzinga
07:01AM EST  Bio-Techne and Akoya Biosciences Partner to Deliver Automated Spatial   PR Newswire
07:00AM EST  Akoya Biosciences, Inc., (NASDAQ: AKYA), The Spatial Biology Company, and Bio-Techne (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities, today announced a partnership to develop the first single-cell, spatial multiomics workflow for comprehensive, unbiased analysis of tissue samples.   GlobeNewswire Inc
Jan 3, 2022
07:00AM EST  BIO-TECHNE TO PRESENT AT THE J.P. MORGAN HEALTHCARE CONFERENCE   PR Newswire
Dec 27, 2021
07:00AM EST  BIO-TECHNE ANNOUNCES APPOINTMENT OF BRENDA EVERSON AS SVP HUMAN RESOURCES   PR Newswire
Dec 21, 2021
07:00AM EST  BIO-TECHNE ANNOUNCES APPOINTMENT OF WILL GEIST AS PRESIDENT, PROTEIN SCIENCES   PR Newswire
Dec 14, 2021
07:10AM EST  Bio-Techne Corporation Announced Agreement for Potential 20% Ownership Investment in Wilson Wolf   Benzinga
07:01AM EST  BIO-TECHNE ANNOUNCES FUTURE WILSON WOLF PURCHASE AGREEMENT   PR Newswire
Dec 8, 2021
07:10AM EST  Bio-Techne Announces Publication Of Lateral Flow Technology Proof-of-Concept Data   RTTNews
07:06AM EST  Bio-Techne Highlights Publication Of Lateral Flow Technology Proof-Of-Concept Data   Benzinga
07:01AM EST  Bio-Techne Announces Publication of Lateral Flow Technology Proof-of-Concept   PR Newswire
Dec 3, 2021
12:19PM EST  Here's How Much You Would Have Made Owning Bio-Techne Stock In The Last 5 Years   Benzinga
Nov 22, 2021
07:00AM EST  Bio-Techne To Present At Upcoming Investor Conferences   PR Newswire
Nov 9, 2021
07:00AM EST  Bio-Techne To Present At The Stifel 2021 Virtual Healthcare Conference   PR Newswire
Nov 8, 2021
07:01AM EST  Asuragen Launches New Kit to Enable Broader Coverage of Gene Variants Linked to   PR Newswire
Nov 4, 2021
04:01PM EDT  Bio-Techne To Present At The Credit Suisse 30th Annual Healthcare Conference   PR Newswire
Nov 3, 2021
07:08AM EDT  Bio-Techne Unveils Commercial Availability Of GMP-Grade Proteins From Dedicated GMP Facility   RTTNews
07:01AM EDT  Bio-Techne Announces Commercial Availability Of GMP-Grade Proteins From   PR Newswire
Nov 2, 2021
04:01PM EDT  Bio-Techne Named in Inc.'s First-Annual Best-Led Companies   PR Newswire
10:54AM EDT  The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US   Benzinga
10:47AM EDT  Bio-Techne Q1 Adj. EPS $1.83 Beats $1.72 Estimate, Sales $257.70M Beat $252.42M Estimate   Benzinga
10:41AM EDT  Earnings Scheduled For November 2, 2021   Benzinga
06:54AM EDT  Bio-Techne To Pay Dividend Of $0.32, Payable Nov. 26, Record Nov.12   RTTNews
06:50AM EDT  Life sciences company Bio-Techne Corp. (TECH) reported Tuesday that first-quarter net earnings surged to $69.62 million or $1.69 per share from $33.40 million or $0.83 per share in the prior-year quarter.   RTTNews
06:37AM EDT  Bio-Techne Q1 GAAP EPS $1.69; Adj EPS $1.83   RTTNews
06:31AM EDT  Bio-Techne Declares Dividend   PR Newswire
06:30AM EDT  Bio-Techne Releases First Quarter Fiscal 2022 Results   PR Newswire
Nov 1, 2021
11:03AM EDT  Bio-Techne's Earnings: A Preview   Benzinga
Oct 31, 2021
02:24PM EDT  The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline   Benzinga
Oct 13, 2021
01:38PM EDT  Bio-Techne Announces ExoDx Prostate Test Data Publication in the Journal of Prostate Cancer and Prostatic Diseases   Benzinga
07:00AM EDT  Bio-Techne Announces ExoDx Prostate Test Data Publication in the Journal of   PR Newswire
Oct 11, 2021
07:00AM EDT  Bio-Techne To Host Conference Call On November 2, 2021 To Announce First   PR Newswire
Sep 16, 2021
07:48AM EDT  The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study   Benzinga
Sep 15, 2021
06:07AM EDT  A Peek Into The Markets: US Stock Futures Rise Ahead Of Economic Data; Crude Oil Gains 1%   Benzinga
04:30AM EDT  Keybanc Upgrades Bio-Techne to Overweight, Announces $600 Price Target   Benzinga
Sep 14, 2021
07:50AM EDT  The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout   Benzinga
07:06AM EDT  Bio-Techne Launches ExCellerate IPSC Expansion Medium   RTTNews
07:01AM EDT  Bio-Techne Launches ExCellerate(tm) iPSC Expansion Medium   PR Newswire
Sep 8, 2021
07:31AM EDT  Life sciences company Bio-Techne (TECH) and Carterra Inc. announced Wednesday a clinical research collaboration studying COVID-19 variants. New variants, such as Delta, can be more easily transmitted and more likely to evade the immune response of vaccinated or previously infected people.   RTTNews
07:12AM EDT  Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19 Variant Analysis   Benzinga
07:10AM EDT  Bio-Techne, Carterra Initiate Clinical Research Collaboration For COVID-19 Variant Analysis   RTTNews
07:00AM EDT  Bio-Techne And Carterra Initiate A Clinical Research Collaboration For COVID-19   PR Newswire
Sep 3, 2021
07:31AM EDT  The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself   Benzinga
Sep 2, 2021
07:00AM EDT  Bio-Techne To Present At The 2021 Virtual Wells Fargo Healthcare Conference   PR Newswire
Aug 31, 2021
08:15AM EDT  The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical   Benzinga
Aug 24, 2021
10:42PM EDT  S&P Dow Jones Indices said it will make changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 effective prior to the opening of trading on Monday, August 30. S&P MidCap 400 constituent Bio-Techne Corp. (TECH) will replace Maxim Integrated Products Inc. (MXIM) in the S&P 500.   RTTNews
06:04PM EDT  Bio-Techne Set to Join S&P 500; Saia, Mimecast & Option Care Health to Join S&P   PR Newswire
05:21PM EDT  Bio-Techne Set To Join S&P 500; To Replace Maxim Integrated Products   Benzinga
Aug 10, 2021
02:42PM EDT  The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs   Benzinga
Aug 6, 2021
07:42AM EDT  The Daily Biotech Pulse: Dicerna Slips On Data, Novavax Tightlipped On US Vaccine Approval, Adagio IPO   Benzinga
Aug 5, 2021
07:20AM EDT  Recap: Bio-Techne Q4 Earnings   Benzinga
06:49AM EDT  Bio-Techne Q4 Organic Revenue Increases By 39% Or 47% Reported To $259.0 Mln   RTTNews
06:48AM EDT  Bio-Techne Q4 Adj. EPS $1.87 Beats $1.70 Estimate, Sales $259.03M Beat $244.62M Estimate   Benzinga
06:30AM EDT  Bio-Techne Declares Dividend   PR Newswire
06:30AM EDT  Bio-Techne Releases Fourth Quarter Fiscal 2021 Results   PR Newswire
04:08AM EDT  Earnings Scheduled For August 5, 2021   Benzinga
Aug 4, 2021
09:24AM EDT  Bio-Techne Corp. (TECH) said that its RNAscope technology aids in the retrospective tissue diagnosis of covid-19 in cases with no previous testing for SARS-CoV-2.   RTTNews
07:15AM EDT  TECH :RNAscope Tech Aids In Retrospective Tissue Diagnosis Of COVID-19 In Cases With No Previous Testing For SARS-CoV-2   RTTNews
07:06AM EDT  Bio-Techne Says CDC Scientists Recently Highlighted 'the importance of fixed tissue analysis for retrospective diagnosis of SARS-CoV-2 infection and characterization of viral strains'   Benzinga
07:00AM EDT  Bio-Techne's RNAscope(tm) Technology Aids in the Retrospective Tissue Diagnosis   PR Newswire
Aug 3, 2021
07:00AM EDT  Bio-Techne Announces 2021 Investor Day and Webcast   PR Newswire
Jul 30, 2021
07:54AM EDT  The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs   Benzinga
Jul 28, 2021
07:00AM EDT  Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay   PR Newswire
Jul 27, 2021
11:13AM EDT  Bio-Techne Announces Commercial Release of RNAscope HiPlex V2 Assay for Single Cell Validation and Spatial Transcriptomic Profiling of Complex Tissues on FFPE, Fixed and Fresh Frozen Samples   Benzinga
Jul 23, 2021
07:45AM EDT  The Daily Biotech Pulse: Acorda Spikes On Distribution Deal, Alzamend Soars On Data, Pfizer-BioNTech To Supply More Vaccine Doses, 3 IPOs   Benzinga
Jul 22, 2021
11:34AM EDT  The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, Absci IPO   Benzinga
Jul 21, 2021
07:52AM EDT  The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay   Benzinga
Jul 13, 2021
08:05AM EDT  The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data   Benzinga
07:00AM EDT  Bio-Techne To Host Conference Call On August 5, 2021 To Announce Fourth Quarter   PR Newswire
Jul 12, 2021
10:14AM EDT  Stocks That Hit 52-Week Highs On Monday   Benzinga
Jul 8, 2021
07:45AM EDT  The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test   Benzinga
Jul 2, 2021
07:38AM EDT  The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures   Benzinga
Jun 29, 2021
10:27AM EDT  UPDATE: SVB Leerink On Bio-Techne Price Target Increase: Firm Continues To View Co. As High-Growth Research Tools Engine With A Consumables-Heavy Business Driving Growth In Key End-Markets Of Preclinical Discovery, Proteomics, Cell Therapy, Liquid Biopsy.   Benzinga
08:18AM EDT  10 Biggest Price Target Changes For Tuesday   Benzinga
06:36AM EDT  SVB Leerink Maintains Outperform on Bio-Techne, Raises Price Target to $480   Benzinga
Jun 28, 2021
07:04AM EDT  Bio-techne Opens New Ireland Facility Located In Dublin   RTTNews
07:00AM EDT  Bio-techne Announces Opening Of New Ireland Facility   PR Newswire
Jun 24, 2021
07:16AM EDT  Bio-Techne, Catamaran Bio Expand Collaboration For CAR-NK Cell Manufacturing Technologies   RTTNews
07:11AM EDT  Bio-Techne And Catamaran Bio Announce Expansion Of Collaboration For CAR-NK Cell Manufacturing Technologies To Include Development Of 'novel cell expansion technologies for use in the manufacturing of CAR-NK cell therapy products'   Benzinga
07:11AM EDT  Bio-Techne And Catamaran Bio Announce Expanded Collaboration For CAR-NK Cell Manufacturing Technologies   RTTNews
07:01AM EDT  Bio-Techne and Catamaran Bio Announce Expanded Collaboration for CAR-NK Cell   PR Newswire
Jun 22, 2021
08:12AM EDT  The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal   Benzinga
Jun 18, 2021
08:08AM EDT  Argus Research Maintains Buy on Bio-Techne, Raises Price Target to $490   Benzinga
07:46AM EDT  The Daily Biotech Pulse: Orphazyme Falters At FDA, Athira's CEO Placed On Temporary Leave, 5 IPOs   Benzinga
Jun 15, 2021
08:07AM EDT  The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda   Benzinga
07:00AM EDT  Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) (Renalytix or the Company) today reported financial results for the quarter and nine months ended March 31, 2021.   GlobeNewswire Inc
Jun 10, 2021
07:21AM EDT  Bio-Techne Partners With Autolomous To Implement Electronic Batch Record System, AutoloMATE   RTTNews
07:00AM EDT  Bio-Techne Further Enhances Its Gene Engineering & Cell & Gene Therapy   PR Newswire
Jun 8, 2021
07:00AM EDT  Bio-Techne Joins Cell and Gene Therapy Catapult Process Analytical Technology   PR Newswire
Jun 2, 2021
11:41AM EDT  Kantaro's Semi-Quantitative Antibody Test Kit Receives Health Canada Authorization Under The COVID-19 Interim Order   RTTNews
11:36AM EDT  Kantaro's Semi-Quantitative Antibody Test Kit Receives Health Canada Authorization Under the COVID-19 Interim Order. BZ NOTE: Kantaro Is A Joint Venture Between Mount Sinai Health System, RenalytixAI And Bio-Techne   Benzinga
11:35AM EDT  Kantaro's Semi-Quantitative Antibody Test Kit Receives Health Canada   PR Newswire
May 19, 2021
07:13AM EDT  Bio-Techne To Present At The Jefferies Virtual Healthcare Conference Jun. 3   Benzinga
07:00AM EDT  Bio-Techne To Present At The Jefferies Virtual Healthcare Conference   PR Newswire
May 18, 2021
07:04AM EDT  Bio-Techne And Narayana Nethralaya Collaborate On Use Of Ella For Ophthalmic Disorder Diagnostic Applications   Benzinga
07:00AM EDT  Bio-Techne and Narayana Nethralaya Collaborate on the use of Ella for   PR Newswire
May 10, 2021
07:15AM EDT  Bio-Techne Provides Update On Co's AmplideX   Benzinga
07:12AM EDT  Bio-Techne Provides an Update on its AmplideX   Benzinga
07:00AM EDT  Multisite Study Demonstrates Utility of Asuragen Kit for Identifying Variants   PR Newswire
May 7, 2021
11:00AM EDT  Evolve ETFs Virtually Opens the Market   PR Newswire
May 6, 2021
07:49AM EDT  The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom   Benzinga
07:35AM EDT  Bio-Techne Q3 Profit Tops Estimates   RTTNews
07:05AM EDT  Bio-Techne Declares A Dividend Of $0.32 Pr/Shr, Record May 17/Payable May 28   RTTNews
06:37AM EDT  Bio-Techne Q3 Adj. EPS $1.79 Beats $1.55 Estimate, Sales $243.60M Beat $228.22M Estimate   Benzinga
06:32AM EDT  Bio-Techne Q3 GAAP EPS $1.12; Adj EPS $1.79   RTTNews
06:30AM EDT  Bio-Techne Releases Third Quarter Fiscal 2021 Results   PR Newswire
06:30AM EDT  Bio-Techne Declares Dividend   PR Newswire
04:17AM EDT  Earnings Scheduled For May 6, 2021   Benzinga
May 4, 2021
02:21PM EDT  Kantaro's COVID-SeroKlir Antibody Test Named As A Finalist For Fast Company's   PR Newswire
07:22AM EDT  Bio-Techne, 908 Devices Announce Joint Collaboration To Develop Extended Workflow Solution For Protein Characterization   RTTNews
07:15AM EDT  Bio-Techne And 908 Devices Announce Joint Collaboration   Benzinga
07:00AM EDT  908 Devices and Bio-Techne Announce Joint Collaboration   Business Wire
Apr 27, 2021
07:41AM EDT  The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout   Benzinga
07:39AM EDT  Bio-Techne Announces Commercial Release Of Novel DNAscope   RTTNews
07:06AM EDT  Bio-Techne Announces Commercial Release Of Novel DNAscope In Situ Hybridization Assays For Chromogenic Detection Of DNA Copy Number and Structural Variations   Benzinga
07:01AM EDT  Hybridization Assays for Chromogenic Detection of DNA Copy Number and Structural Variations   PR Newswire
Apr 23, 2021
07:28AM EDT  The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs   Benzinga
Apr 22, 2021
08:09AM EDT  The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs   Benzinga
Apr 15, 2021
07:49AM EDT  The Daily Biotech Pulse: Merck Shelves 2 COVID-19 Studies, Bristol-Myers Squibb Gets European Regulatory Nod, InspireMD's Reverse Split   Benzinga
07:22AM EDT  Bio-Techne Announces Launch Of Professional Assay Services   RTTNews
07:00AM EDT  Bio-Techne Announces Launch of Professional Assay Services - Dedicated Source   PR Newswire
Apr 14, 2021
07:51AM EDT  The Daily Biotech Pulse: Novavax CFO Departs, Zai Lab Inks Cancer Drug Collaboration, FDA Nod For Gilead   Benzinga
07:09AM EDT  Bio-Techne Announces License Agreement For Use Of Proprietary Bio-Techne Antibody By Xencor   RTTNews
07:01AM EDT  Bio-Techne Announces Licensing of Proprietary Antibody to Xencor for   PR Newswire
Apr 8, 2021
07:06AM EDT  Bio-Techne Unveils Abby Automated Western System For Simple Western And Introduces Stellar Modules For Jess   RTTNews
07:02AM EDT  Bio-Techne Announces Commercial Release Of Abby Automated Western System For Simple Western And Introduces Stellar Modules For Jess   Benzinga
07:01AM EDT  Bio-Techne Announces Commercial Release of Abby Automated Western System for   PR Newswire
Apr 6, 2021
04:03PM EDT  Bio-Techne Completes Acquisition Of Asuragen   RTTNews
04:01PM EDT  Bio-Techne Completes Acquisition of Asuragen, Inc.   PR Newswire
07:01AM EDT  Bio-Techne To Host Conference Call On May 6, 2021 To Announce Third Quarter   PR Newswire
Mar 29, 2021
07:07AM EDT  Bio-Techne Announces Launch of Cultrex UltiMatrix BME to Support Organoid and Pluripotent Stem Cell Cultures   Benzinga
07:00AM EDT  Bio-Techne Announces Launch of Cultrex UltiMatrix BME to Support Organoid and   PR Newswire
Mar 26, 2021
07:00AM EDT  Bio-Techne Announces Receipt of COVID-19 Innovation Award from CiteAb   PR Newswire
Mar 23, 2021
07:14AM EDT  Bio-Techne's Exosome Diagnostics Laboratory Announces CE-IVD Certification For ExoDx Prostate Test   Benzinga
07:00AM EDT  Bio-Techne's Exosome Diagnostics Laboratory Announces CE-IVD Certification For   PR Newswire
Mar 15, 2021
07:04AM EDT  Bio-Techne Announces ISO 9001:2015 Certification For Its Bristol Manufacturing Facility   RTTNews
07:00AM EDT  Bio-Techne Announces ISO 9001:2015 Certification for its Bristol Manufacturing   PR Newswire
Mar 10, 2021
10:32AM EST  Innovative Companies for 2021 and Ranked First in the Joint Ventures Category   PR Newswire
Mar 8, 2021
02:21PM EST  Bio-Techne shares were trading higher after Stephens & Co upgraded the stock from Equal-Weight to Overweight and raised the price target from $380 to $425 per share.   Benzinga
10:04AM EST  Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2021   Benzinga
09:53AM EST  Stephens & Co. Upgrades Bio-Techne to Overweight, Raises Price Target to $425   Benzinga
07:08AM EST  Bio-Techne Publishes Data On Its ExoTRU Kidney Transplant Rejection Test   Benzinga
07:00AM EST  Bio-Techne Announces ExoTRU Kidney Transplant Rejection Assay Data Publication   PR Newswire
Mar 4, 2021
08:12AM EST  The Daily Biotech Pulse: FDA Nod For Pfizer, Kiniksa Rises On Commercialization Pact With Regeneron, Bio-Techne To Buy Diagnostic Company   Benzinga
06:37AM EST  Bio-Techne Scoops Up Genetics And Oncology-Focused Diagnostics Firm   Benzinga
Mar 3, 2021
05:07PM EST  Bio-Techne To Acquire Asuragen   RTTNews
04:47PM EST  Bio-Techne To Acquire Asuragen For $215M In Cash Plus Contingent Consederion Of Up To $105M Upon The Achieventmt Of Certain Milestones   Benzinga
04:45PM EST  Bio-Techne to Acquire Asuragen   PR Newswire
Mar 2, 2021
07:01AM EST  Bio-Techne To Present At The Barclays Global Healthcare Conference   PR Newswire
Mar 1, 2021
07:12AM EST  Bio-Techne's Exosome Diagnostics Laboratory Announces Reimbursement Contract With Humana Covering Its ExoDx Prostate Prostate Test   Benzinga
07:00AM EST  Bio-Techne's Exosome Diagnostics Laboratory Announces Reimbursement Contract   PR Newswire
Feb 25, 2021
07:52AM EST  Bio-Techne Corp Announces ISO 14001:2015 Certification For EMEA REgion Of Bio-Techne   Benzinga
07:01AM EST  Bio-Techne Announces ISO 14001:2015 Certification for the EMEA region of   PR Newswire
Feb 23, 2021
11:08AM EST  Benzinga's Top Ratings Upgrades, Downgrades For February 23, 2021   Benzinga
07:15AM EST  Bio-Techne, Luminary Agree For Use Of Bio-Techne's TcBuster For Development Of Luminary's CAR-T Cell Therapies   RTTNews
07:04AM EST  Bio-Techne and Luminary Therapeutics Sign License Agreement For Use of Bio-Techne's TcBuster For The Development of Luminary's CAR-T Cell Therapies   Benzinga
07:00AM EST  Bio-Techne's TcBuster(tm) for the development of Luminary's CAR-T cell therapies   PR Newswire
06:02AM EST  Stifel Upgrades Bio-Techne to Buy, Announces $435 Price Target   Benzinga
Feb 17, 2021
07:27AM EST  The Daily Biotech Pulse: Novartis Funding For Gene Therapy Research, Priority Review For Amgen Cancer Drug, Pfizer-BioNTech Vaccine Supply Deal   Benzinga
Feb 16, 2021
07:02AM EST  Bio-Techne To Present At Citi's 2021 Healthcare Services, Medtech, Tools & HCIT   PR Newswire
Feb 11, 2021
07:01AM EST  Bio-Techne Announces Paper Publication In Annals Of Oncology   PR Newswire
Feb 10, 2021
11:34AM EST  Kantaro Biosciences Joint Venture With Mount Sinai, RenalytixAI And Manufacturing Partner Bio-Techne Report FDA Added COVID-SeroKlir To Emergency Use Authorization For 'use of convalescent plasma for treating COVID-19 in hospitalized patients'   Benzinga
11:32AM EST  FDA Adds Kantaro's Semi-Quantitative COVID-19 Antibody Test to Revised   PR Newswire
07:01AM EST  Bio-Techne To Present At The 2021 SVB Leerink Global Healthcare Conference   PR Newswire
Feb 8, 2021
07:35AM EST  Bio-Techne And RenalytixAI Joint Venture Kantaro Biosciences Enters Marketing And Distribution Agreement With Atrys Health; Atrys To Offer Kantaro's SARS-CoV-2 IgG Antibody Test Kits In Select European And South American Countries   Benzinga
07:31AM EST  Kantaro and Atrys Health Partnership Expand Global Footprint of Quantitative   PR Newswire
Feb 3, 2021
01:32PM EST  Citigroup Maintains Neutral on Bio-Techne, Raises Price Target to $400   Benzinga
11:51AM EST  Craig-Hallum Maintains Buy on Bio-Techne, Raises Price Target to $440   Benzinga
07:31AM EST  The Daily Biotech Pulse: Amgen Earnings, GSK-CureVac Vaccine Collaboration, Mallinckrodt FDA Decision   Benzinga
07:30AM EST  Bio-Techne Reports Its ProteinSimple Brand Expanded Its Simple Plex Immunoassay Cartridge Portfolio To Include 9 New Cartridge Formats   Benzinga
07:00AM EST  Bio-Techne Announces Expanded Simple Plex Immunoassay Cartridge Portfolio   PR Newswire
Feb 2, 2021
08:05AM EST  The Daily Biotech Pulse: Vertex, Pfizer Earnings, Tiziana COVID-19 Vaccine Data, Decision Day For Mallinckrodt's Burn Treatment   Benzinga
07:08AM EST  Bio-Techne: Q2 Earnings Insights   Benzinga
06:41AM EST  Bio-Techne Declares Q2 Dividend Of $0.32/Shr; Record Feb 12/payable Feb 26   RTTNews
06:40AM EST  Bio-Techne Corp. (TECH), a global life sciences company, reported second quarter adjusted earnings per share of $1.62 compared to $1.08, a year ago. On average, ten analysts polled by Thomson Reuters expected the company to report profit per share of $1.37, for the quarter. Analysts' estimates typically exclude special items.   RTTNews
06:32AM EST  Bio-Techne Q2 GAAP EPS $1.15; Adj EPS $1.62   RTTNews
06:31AM EST  Bio-Techne Q2 Adj. EPS $1.62 Beats $1.37 Estimate, Sales $224.30M Beat $206.50M Estimate   Benzinga
06:30AM EST  Bio-Techne Declares Dividend   PR Newswire
06:30AM EST  Bio-Techne Releases Second Quarter Fiscal 2021 Results   PR Newswire
04:00AM EST  Earnings Scheduled For February 2, 2021   Benzinga
Jan 30, 2021
01:19PM EST  The Week Ahead In Biotech: Merck, Pfizer In Earnings Mix, Plus Adamas, Mallinckrodt FDA Decisions, IPOs And More   Benzinga
Jan 28, 2021
07:07AM EST  Bio-Techne Unveils Initial Minority Strategic Equity Stake In Changzhou Eminence Biotechnology Co.   RTTNews
07:01AM EST  Bio-Techne Announces Strategic Investment In Eminence   PR Newswire
Jan 21, 2021
08:05AM EST  The Daily Biotech Pulse: Addex Jumps On Positive Data For Out-Licensed Drug, COVID-19 Vaccine Developer Inovio Announces $150M Follow-On Offering, Boston Scientific Goes Shopping   Benzinga
Jan 20, 2021
07:32AM EST  The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study   Benzinga
Jan 15, 2021
07:57AM EST  The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges   Benzinga
Jan 14, 2021
07:01AM EST  Bio-Techne To Host Conference Call On February 2, 2021 To Announce Second   PR Newswire
Jan 8, 2021
07:25AM EST  The Daily Biotech Pulse: Sarepta Gene Therapy Study Readout, Novavax Vaccine Supply Deal, 2 IPOs   Benzinga
Jan 6, 2021
09:07AM EST  Bio-Techne Highlights Launch Of ScaleReady Joint Venture   Benzinga
Dec 29, 2020
08:09AM EST  The Daily Biotech Pulse: FDA Nod For Amphastar's Generic Glucagon, Arcturus Sinks On Vaccine Data, Decision Day For Osmotica   Benzinga
Dec 23, 2020
08:31AM EST  The Daily Biotech Pulse: Supernus Issues Positive ADHD Readout, Sorrento Files For Emergency Use Authorization For Rapid COVID-19 Test, Inhibikase To Make Wall Street Debut   Benzinga
Dec 22, 2020
07:45AM EST  The Daily Biotech Pulse: Ziopharm To Start Blood Cancer Study, Chemocentryx & Soligenix Slump On Adverse Clinical Trial Outcomes   Benzinga
Dec 21, 2020
07:00AM EST  Bio-Techne To Present At The 39th Annual J.P. Morgan Healthcare Conference   PR Newswire
Dec 2, 2020
07:24AM EST  Bio-Techne Corp. (TECH) and Regulus Therapeutics Inc. (RGLS) announced Wednesday a collaboration to support Regulus with biomarker analysis for the clinical development of RGLS4326, an Autosomal Dominant Polycystic Kidney Disease (ADPKD) treatment.   RTTNews
07:11AM EST  Regulus Therapeutics, Bio-Techne Collaborate For Biomarker Development   RTTNews
07:09AM EST  Regulus Therapeutics Collaborates With Bio-Techne For Biomarker Development   Benzinga
Nov 25, 2020
07:48AM EST  Kantaro Receives Emergency Use Authorization For   RTTNews
07:37AM EST  RenalytixAI Joint Venture Kantaro Biosciences Receives FDA Emergency Use Authorization ForIts COVID-SeroKlir Semi-Quantitative COVID-19 Antibody Test Kit; Kits Being MAnufactured Through Partnership With Bio-Techne   Benzinga
07:36AM EST  Kantaro Receives FDA Emergency Use Authorization For COVID-SeroKlir   RTTNews
07:30AM EST  Antibody Test Kit that Detects the Presence and Level of SARS-CoV-2 IgG Antibodies   PR Newswire
Nov 11, 2020
07:01AM EST  Bio-Techne To Present At The Stephens Annual Investment Conference 2020   PR Newswire
Nov 10, 2020
08:40AM EST  The Daily Biotech Pulse: Lilly's COVID-19 Antibody Treatment Approved For Emergency Use, Supernus Faces Twin Regulatory Setbacks, Revance, Arena Flunk Midstage Studies   Benzinga
Nov 6, 2020
07:47AM EST  The Daily Biotech Pulse: Novartis Drug Flunks COVID-19 Study, Molecular Templates' Blood Cancer Study Placed On Partial Hold   Benzinga
05:29AM EST  SVB Leerink Maintains Outperform on Bio-Techne, Raises Price Target to $320   Benzinga
Nov 5, 2020
06:54AM EST  Life sciences company Bio-Techne Corp. (TECH) reported Thursday that its first-quarter net earnings surged to $33.40 million or $0.83 per share from $14.40 million or $0.37 per share in the prior-year quarter.   RTTNews
06:36AM EST  Bio-Techne Q1 Adj. EPS $1.43 Beats $1.09 Estimate, Sales $204.20M Beat $184.83M Estimate   Benzinga
06:33AM EST  Bio-Techne Declares Dividend Of $0.32, Payable Nov. 27, Record Nov. 16   RTTNews
06:32AM EST  Bio-Techne Q1 GAAP EPS $0.83 Vs $0.37 Year Ago   RTTNews
06:30AM EST  Bio-Techne Releases First Quarter Fiscal 2021 Results   PR Newswire
06:30AM EST  Bio-Techne Declares Dividend   PR Newswire
04:34AM EST  Earnings Scheduled For November 5, 2020   Benzinga
Nov 4, 2020
07:00AM EST  Bio-Techne To Present At The Stifel 2020 Virtual Healthcare Conference   PR Newswire
Nov 2, 2020
08:59AM EST  Morgan Stanley Maintains Equal-Weight on Rocket Companies, Lowers Price Target to $23   Benzinga
07:01AM EST  Bio-Techne To Present At The 29th Annual Credit Suisse Virtual Healthcare   PR Newswire
Oct 28, 2020
07:31AM EDT  EKF and Kantaro Partner to Market Quantitative COVID-19 Antibody Testing in the   PR Newswire
Oct 26, 2020
07:59AM EDT  Kantaro Biosciences Receives CE Marking For SARS-CoV-2 IgG   RTTNews
07:47AM EDT  Kantaro Gets CE Marking For COVID-SeroKlir And COVID-SeroIndex, Kantaro's Quantitative SARS-CoV-2 IgG Antibody Test Kits   RTTNews
07:36AM EDT  Kantaro Biosciences And Partner Bio-Techne Receive CE Mark For COVID-SeroKlir And COVID-SeroIndex SARS-CoV-2 IgG Antibody Test Kits   Benzinga
07:31AM EDT  CE Mark Approval Granted to Kantaro COVID-SeroKlir and COVID-SeroIndex   PR Newswire
Oct 19, 2020
07:14AM EDT  Bio-Techne Releases SARS-CoV-2 Multi-Antigen Serology   RTTNews
07:10AM EDT  Bio-Techne Announces Commercial Release Of New SARS-CoV-2 Multi-Antigen Serology Assay Kit For Simple Western   Benzinga
07:04AM EDT  Bio-Techne Announces Commercial Release Of SARS-CoV-2 Multi-Antigen Serology Assay Kit For Simple Western   RTTNews
07:00AM EDT  Bio-Techne Announces Commercial Release Of New SARS-CoV-2 Multi-Antigen   PR Newswire
Oct 15, 2020
07:08AM EDT  Bio-Techne Announces ISO 13485:2016 Certification For Woburn, MA Manufacturing Facility   Benzinga
07:01AM EDT  Bio-Techne Announces ISO 13485:2016 Certification for the Woburn, MA   PR Newswire
Oct 13, 2020
07:00AM EDT  Bio-Techne To Host Conference Call On November 5, 2020 To Announce First   PR Newswire
Oct 1, 2020
07:06AM EDT  Bio-Techne Announces Opening Of Its New Canadian Office In Toronto   RTTNews
07:00AM EDT  Bio-Techne Announces Opening Of New Canadian Facility   PR Newswire
Sep 30, 2020
07:23AM EDT  Atlantic Equities Initiates Coverage On Bio-Techne with Overweight Rating, Announces Price Target of $365   Benzinga
07:03AM EDT  Bio-Techne Unveils Opening Of Its GMP Manufacturing Facility In St. Paul, MN   RTTNews
07:00AM EDT  Bio-Techne Announces Grand Opening Of GMP Manufacturing Facility   PR Newswire
Sep 23, 2020
07:12AM EDT  Bio-Techne Announces Publication Of ExoDx Prostate Test Study In Patients With Prior Negative Prostate Biopsy   RTTNews
07:03AM EDT  Bio-Techne Announces Commercial Release Of New Co-Detection Assays For Simultaneous Detection Of RNA And Protein On The Same Sample   Benzinga
07:00AM EDT  Bio-Techne Announces Publication Of ExoDx Prostate Test Study In Patients With   PR Newswire
Sep 22, 2020
07:05AM EDT  Bio-Techne Announces Commercial Release Of New Co-Detection Assays For Simultaneous Detection Of RNA And Protein On The Same Sample   Benzinga
07:01AM EDT  Bio-Techne Announces Commercial Release Of New Co-Detection Assays For   PR Newswire
Sep 21, 2020
07:10AM EDT  Bio-Techne Rebrands B-MoGen Biotechnologies As Part Of The R&D Systems Product Portfolio   Benzinga
07:00AM EDT  Bio-Techne Rebrands B-MoGen Biotechnologies As Part Of The R&D Systems Product   PR Newswire
Sep 17, 2020
07:18AM EDT  Bio-Techne Corp. (TECH) and Netherlands-based Qiagen NV (QGENF) announced Thursday the expansion and extension of a non-exclusive partnership to co-market exosome technology to existing and potential biopharma partners as well as the joint development of new exosome based products.   RTTNews
07:07AM EDT  Bio-Techne And QIAGEN Announce Expansion And Extension Of Exosome Partnership   Benzinga
07:03AM EDT  Bio-Techne And QIAGEN Announce Expansion And Extension Of Non-exclusive Partnership   RTTNews
07:00AM EDT  Bio-Techne and QIAGEN Announce Expansion and Extension of Exosome Partnership   PR Newswire
Sep 8, 2020
07:04AM EDT  Bio-Techne And Hall Of Famer Cal Ripken Jr -Announce Partnership   RTTNews
07:00AM EDT  Bio-Techne And Hall Of Famer Cal Ripken Jr -Announce Partnership To Raise   PR Newswire
Sep 3, 2020
07:00AM EDT  Bio-Techne To Present At The 2020 Wells Fargo Virtual Healthcare Conference   PR Newswire
Aug 19, 2020
08:52AM EDT  Bio-Techne Corp. (TECH) announced the automation of RNAscope COVID-19 probes on BOND RX, Leica Biosystems's staining platform, which allow researchers the ability to automate their COVID-19 research protocols, reducing manual labor and turnaround time.   RTTNews


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC